PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CNTA vs. MPTI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CNTA and MPTI is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

CNTA vs. MPTI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Centessa Pharmaceuticals Limited (CNTA) and M-tron Industries Inc (MPTI). The values are adjusted to include any dividend payments, if applicable.

-20.00%0.00%20.00%40.00%60.00%80.00%SeptemberOctoberNovemberDecember2025February
37.30%
21.93%
CNTA
MPTI

Key characteristics

Sharpe Ratio

CNTA:

0.69

MPTI:

0.08

Sortino Ratio

CNTA:

1.34

MPTI:

0.59

Omega Ratio

CNTA:

1.15

MPTI:

1.08

Calmar Ratio

CNTA:

0.62

MPTI:

0.13

Martin Ratio

CNTA:

2.83

MPTI:

0.27

Ulcer Index

CNTA:

15.02%

MPTI:

21.22%

Daily Std Dev

CNTA:

61.20%

MPTI:

66.58%

Max Drawdown

CNTA:

-88.19%

MPTI:

-46.41%

Current Drawdown

CNTA:

-34.72%

MPTI:

-34.38%

Fundamentals

Market Cap

CNTA:

$2.10B

MPTI:

$141.51M

EPS

CNTA:

-$1.52

MPTI:

$2.00

Total Revenue (TTM)

CNTA:

$0.00

MPTI:

$36.21M

Gross Profit (TTM)

CNTA:

-$712.39K

MPTI:

$16.59M

EBITDA (TTM)

CNTA:

-$158.13M

MPTI:

$7.26M

Returns By Period

In the year-to-date period, CNTA achieves a 0.00% return, which is significantly higher than MPTI's -5.18% return.


CNTA

YTD

0.00%

1M

1.76%

6M

37.30%

1Y

61.06%

5Y*

N/A

10Y*

N/A

MPTI

YTD

-5.18%

1M

-20.83%

6M

21.93%

1Y

22.45%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CNTA vs. MPTI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CNTA
The Risk-Adjusted Performance Rank of CNTA is 6868
Overall Rank
The Sharpe Ratio Rank of CNTA is 7070
Sharpe Ratio Rank
The Sortino Ratio Rank of CNTA is 6767
Sortino Ratio Rank
The Omega Ratio Rank of CNTA is 6363
Omega Ratio Rank
The Calmar Ratio Rank of CNTA is 7171
Calmar Ratio Rank
The Martin Ratio Rank of CNTA is 7272
Martin Ratio Rank

MPTI
The Risk-Adjusted Performance Rank of MPTI is 4949
Overall Rank
The Sharpe Ratio Rank of MPTI is 4949
Sharpe Ratio Rank
The Sortino Ratio Rank of MPTI is 4848
Sortino Ratio Rank
The Omega Ratio Rank of MPTI is 4848
Omega Ratio Rank
The Calmar Ratio Rank of MPTI is 5252
Calmar Ratio Rank
The Martin Ratio Rank of MPTI is 5050
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CNTA vs. MPTI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Centessa Pharmaceuticals Limited (CNTA) and M-tron Industries Inc (MPTI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CNTA, currently valued at 0.69, compared to the broader market-2.000.002.000.690.08
The chart of Sortino ratio for CNTA, currently valued at 1.34, compared to the broader market-4.00-2.000.002.004.006.001.340.59
The chart of Omega ratio for CNTA, currently valued at 1.15, compared to the broader market0.501.001.502.001.151.08
The chart of Calmar ratio for CNTA, currently valued at 1.25, compared to the broader market0.002.004.006.001.250.13
The chart of Martin ratio for CNTA, currently valued at 2.83, compared to the broader market-10.000.0010.0020.0030.002.830.27
CNTA
MPTI

The current CNTA Sharpe Ratio is 0.69, which is higher than the MPTI Sharpe Ratio of 0.08. The chart below compares the historical Sharpe Ratios of CNTA and MPTI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.00SeptemberOctoberNovemberDecember2025February
0.69
0.08
CNTA
MPTI

Dividends

CNTA vs. MPTI - Dividend Comparison

Neither CNTA nor MPTI has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

CNTA vs. MPTI - Drawdown Comparison

The maximum CNTA drawdown since its inception was -88.19%, which is greater than MPTI's maximum drawdown of -46.41%. Use the drawdown chart below to compare losses from any high point for CNTA and MPTI. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-11.98%
-34.38%
CNTA
MPTI

Volatility

CNTA vs. MPTI - Volatility Comparison

Centessa Pharmaceuticals Limited (CNTA) and M-tron Industries Inc (MPTI) have volatilities of 15.97% and 15.38%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
15.97%
15.38%
CNTA
MPTI

Financials

CNTA vs. MPTI - Financials Comparison

This section allows you to compare key financial metrics between Centessa Pharmaceuticals Limited and M-tron Industries Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab